| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
In the last three months, 12 analysts have published ratings on Allstate (NYSE:ALL), offering a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 6 | 1 | 2 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 2 | 3 | 1 | 1 | 0 |
| 3M Ago | 1 | 1 | 0 | 1 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $213.17, a high estimate of $260.00, and a low estimate of $22.00. Surpassing the previous average price target of $204.36, the current average has increased by 4.31%.
A comprehensive examination of how financial experts perceive Allstate is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Tracy Benguigui | Wolfe Research | Announces | Outperform | $235.00 | - |
| Michael Zaremski | BMO Capital | Raises | Outperform | $235.00 | $230.00 |
| Paul Newsome | Piper Sandler | Raises | Overweight | $22.00 | $20.00 |
| Andrew Andersen | Jefferies | Raises | Buy | $255.00 | $254.00 |
| Meyer Shields | Keefe, Bruyette & Woods | Raises | Outperform | $246.00 | $237.00 |
| Elyse Greenspan | Wells Fargo | Raises | Equal-Weight | $202.00 | $197.00 |
| C. Gregory Peters | Raymond James | Raises | Strong Buy | $260.00 | $250.00 |
| Bob Huang | Morgan Stanley | Raises | Overweight | $245.00 | $235.00 |
| Alex Scott | Barclays | Raises | Underweight | $198.00 | $188.00 |
| Meyer Shields | Keefe, Bruyette & Woods | Raises | Outperform | $237.00 | $235.00 |
| Brian Meredith | UBS | Raises | Buy | $235.00 | $230.00 |
| Alex Scott | Barclays | Raises | Underweight | $188.00 | $172.00 |
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Allstate's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Allstate analyst ratings.
Allstate is one of the largest US property-casualty insurers in the US. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 6,000 exclusive agents.
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Over the 3M period, Allstate showcased positive performance, achieving a revenue growth rate of 5.68% as of 30 June, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 12.51%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Allstate's ROE excels beyond industry benchmarks, reaching 9.88%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.8%, the company showcases effective utilization of assets.
Debt Management: Allstate's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.37, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ALL
